Abstract
A 65-year-old man underwent coronary artery bypass graft surgery at our tertiary care hospital. Perioperatively, he was transfused with four units of nonirradiated whole blood from first-degree relatives and discharged from the hospital at postoperative day seven. He presented six days later with fever, skin rash, elevated liver enzymes, and progressive pancytopenia. Elevated bilirubin levels and diarrhea were added to the clinical picture over the following days. Clinical findings and results of a skin biopsy specimen were consistent with transfusion-associated graft-versus-host disease. The patient died 20 days after transfusion.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Ahya R., Douglas J. G., Watson H. G. Transfusion associated graft versus host disease in an immunocompetent individual following coronary artery bypass grafting. Heart. 1998 Sep;80(3):299–300. doi: 10.1136/hrt.80.3.299. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hume H. A., Preiksaitis J. B. Transfusion associated graft-versus-host disease, cytomegalovirus infection and HLA alloimmunization in neonatal and pediatric patients. Transfus Sci. 1999 Aug;21(1):73–95. doi: 10.1016/s0955-3886(99)00067-3. [DOI] [PubMed] [Google Scholar]
- Hutchinson Kendra, Kopko Patricia M., Muto Kathryn N., Tuscano Joseph, O'Donnell Robert T., Holland Paul V., Richman Carol, Paglieroni Teresa G., Wun Theodore. Early diagnosis and successful treatment of a patient with transfusion-associated GVHD with autologous peripheral blood progenitor cell transplantation. Transfusion. 2002 Dec;42(12):1567–1572. doi: 10.1046/j.1537-2995.2002.00253.x. [DOI] [PubMed] [Google Scholar]
- Ohto H., Anderson K. C. Survey of transfusion-associated graft-versus-host disease in immunocompetent recipients. Transfus Med Rev. 1996 Jan;10(1):31–43. doi: 10.1016/s0887-7963(96)80121-0. [DOI] [PubMed] [Google Scholar]
- Ohto H., Yasuda H., Noguchi M., Abe R. Risk of transfusion-associated graft-versus-host disease as a result of directed donations from relatives. Transfusion. 1992 Sep;32(7):691–693. doi: 10.1046/j.1537-2995.1992.32792391051.x. [DOI] [PubMed] [Google Scholar]
- Petz L. D., Calhoun L., Yam P., Cecka M., Schiller G., Faitlowicz A. R., Herron R., Sayah D., Wallace R. B., Belldegrun A. Transfusion-associated graft-versus-host disease in immunocompetent patients: report of a fatal case associated with transfusion of blood from a second-degree relative, and a survey of predisposing factors. Transfusion. 1993 Sep;33(9):742–750. doi: 10.1046/j.1537-2995.1993.33994025025.x. [DOI] [PubMed] [Google Scholar]
- Schroeder Marlis L. Transfusion-associated graft-versus-host disease. Br J Haematol. 2002 May;117(2):275–287. doi: 10.1046/j.1365-2141.2002.03450.x. [DOI] [PubMed] [Google Scholar]
- Vogelsang G. B. Transfusion-associated graft-versus-host disease in nonimmunocompromised hosts. Transfusion. 1990 Feb;30(2):101–103. doi: 10.1046/j.1537-2995.1990.30290162892.x. [DOI] [PubMed] [Google Scholar]
- Yasuura K., Okamoto H., Matsuura A. Transfusion-associated graft-versus-host disease with transfusion practice in cardiac surgery. J Cardiovasc Surg (Torino) 2000 Jun;41(3):377–380. [PubMed] [Google Scholar]
- van der Mast B. J., Hornstra N., Ruigrok M. B., Claas F. H., van Rood J. J., Lagaaij E. L. Transfusion-associated graft-versus-host disease in immunocompetent patients: a self-protective mechanism. Lancet. 1994 Mar 26;343(8900):753–757. doi: 10.1016/s0140-6736(94)91836-8. [DOI] [PubMed] [Google Scholar]
- van der Mast Barbara J., van den Dorpel Marinus A., Drabbels Jos J. M., Claas Frans H. J., Weimar Willem. Transfusion-associated graft vs. host disease after donor-specific leukocyte transfusion before kidney transplantation. Clin Transplant. 2003 Oct;17(5):477–483. doi: 10.1034/j.1399-0012.2003.00074.x. [DOI] [PubMed] [Google Scholar]